Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Zentalis Pharmaceuticals Inc Is A Clinical-Stage Biopharmaceutical Company Developing Azenosertib (Zn-C3), A Potentially First-In-Class And Best-In-Class Wee1 Inhibitor For Patients With Cyclin E1-Positive Platinum-Resistant Ovarian Cancer (Cyclin E1+ Proc). The Company Manages Its Operations As A Single Segment For The Purposes Of Assessing Performance And Making Operating Decisions.